PROFESSOR Akiko Shimamura
Professor of Pediatrics at Harvard Medical School
Holds the Samuel E. Lux IV Chair in Hematology/Oncology
Professor Akiko Shimamura directs the Bone Marrow Failure and MDS Program at the Dana Farber/Boston Children’s Cancer and Blood Disorders Center.
Her research spans laboratory and clinical studies to improve diagnosis and treatment of bone marrow failure and predisposition to myeloid malignancies. Dr. Shimamura founded and directs the North American Shwachman Diamond Syndrome Registry.
She serves on the Executive Committee of the North American Pediatric Aplastic Anemia Consortium (NAPAAC), a working group of over 30 pediatric hematology centers. Her work has led to the identification of genetic causes of bone marrow failure and leukemia predisposition.
Her studies have informed evidence-based integration of genomic testing into diagnostic algorithms for these disorders. Dr. Shimamura chaired the Germline Genomics Subcommittee of the ASH Precision Medicine Task Force. She serves on the medical and scientific advisory boards of several foundations including the MDS Foundation and the Shwachman Diamond Syndrome Foundation.
dr Austin G Kulasekararaj
King’s College Hospital, London, England
Honorary Senior Clinical Lecturer
King’s College London, London
Austin Kulasekararaj is a Consultant Haematologist working at King’s College Hospital under the myeloid, allogeneic transplant and bone marrow failure services. He also leads the King’s National PNH service. He did his graduate and post-graduate training in internal medicine in India. He subsequently completed his medical and specialist haematology training at King’s College Hospital, London.
His special interest is bone marrow failure syndromes- aplastic anaemia, PNH and myelodysplastic syndrome. His research interest is in molecular pathogenesis of myelodysplastic syndromes (MDS), especially the role of TP53 and other somatic mutations.
He has contributed to key publications in the field of molecular and immunological aspects of bone marrow failures, especially MDS. He was a Leukaemia and Lymphoma Research foundation (LLR) and British Society of Haematology (BSH) senior clinical research fellow.
Dr. Kulasekararaj is a member of BSH, MDS NCRN working group and EBMT Severe Aplastic Anaemia Working Party (SAAWP).
Dr Austin Kulasekararaj is visiting Melbourne as an Expert-in-Residence of Melbourne Genomics Health Alliance.